Bosentan and cholangitis 
Bosentan and cholangitis Patient Reports February 11, 2012
Bosentan Side Effects Report #4913394-5
Bosentan side effect was reported by a Physician from SPAIN on Jan 31, 2006. Female patient, 73 years of age, was diagnosed with pulmonary hypertension
, osteoporosis and was treated with Bosentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholangitis, jaundice cholestatic, wound . Bosentan dosage: 125 MG, BID, ORAL. During the same period patient was treated with LOSARTAN POTASSIUM, ACENOCOUMAROL, RISEDRONIC ACID. Patient was hospitalized. Patient recovered.Bosentan Side Effects Report #4924542-5
Bosentan side effect was reported by a Physician from SPAIN on Feb 08, 2006. Female patient, 73 years of age, was diagnosed with pulmonary hypertension
and was treated with Bosentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, bile duct stone, biliary dilatation, blood alkaline phosphatase increased, cholangitis, jaundice cholestatic. Bosentan dosage: 125 MG, BID, ORAL. During the same period patient was treated with LOSARTAN POTASSIUM, ACENOCOUMAROL, RISEDRONIC ACID, DOMPERIDONE, FLUOXETINE, CALCIUM, OMEPRAZOLE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.